Home » Stocks » Omnicell

Omnicell, Inc. (OMCL)

Stock Price: $68.59 USD 0.55 (0.81%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 2.93B
Revenue (ttm) 906.40M
Net Income (ttm) 49.09M
Shares Out 42.76M
EPS (ttm) 1.13
PE Ratio 60.70
Forward PE 31.85
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $68.59
Previous Close $68.04
Change ($) 0.55
Change (%) 0.81%
Day's Open 67.96
Day's Range 67.30 - 68.60
Day's Volume 168,577
52-Week Range 54.24 - 94.85

More Stats

Market Cap 2.93B
Enterprise Value 2.85B
Earnings Date (est) Oct 22, 2020
Ex-Dividend Date n/a
Shares Outstanding 42.76M
Float 41.94M
EPS (basic) 1.18
EPS (diluted) 1.13
FCF / Share 2.37
Dividend n/a
Dividend Yield n/a
Earnings Yield 1.65%
FCF Yield 3.45%
Payout Ratio n/a
Shares Short 2.53M
Short Ratio 8.59
Short % of Float 8.73%
Beta 1.00
PE Ratio 60.70
Forward PE 31.85
P/FCF Ratio 29.02
PS Ratio 3.24
PB Ratio 3.28
Revenue 906.40M
Operating Income 51.99M
Net Income 49.09M
Free Cash Flow 101.06M
Net Cash 86.89M
Net Cash / Share 2.03
Gross Margin 48.20%
Operating Margin 5.74%
Profit Margin 5.40%
FCF Margin 11.15%
ROA 3.20%
ROE 5.91%
ROIC 10.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (9)

Buy 6
Overweight 0
Hold 3
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$79.78*
(16.31% upside)
Low
59.0
Current: $68.59
High
90.0
Target: 79.78
*Average 12-month price target from 9 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue897787713696485441381314246222
Revenue Growth13.94%10.47%2.41%43.62%9.9%15.85%21.19%27.9%10.4%-
Gross Profit437372319317248234203171136118
Operating Income78.3544.3911.1521.4145.1949.5835.3027.1316.229.53
Net Income61.3437.7330.529.7630.7630.5223.9816.1810.394.89
Shares Outstanding41.4639.2437.4836.1635.8635.6534.7433.3133.1232.65
Earnings Per Share1.430.930.790.260.840.830.670.470.300.15
EPS Growth53.76%17.72%203.85%-69.05%1.2%23.88%42.55%56.67%100%-
Operating Cash Flow14510424.8349.9038.4965.1655.2639.4831.2420.60
Capital Expenditures-61.66-54.37-30.38-27.79-19.67-22.28-20.10-20.15-12.88-9.10
Free Cash Flow83.3449.59-5.5522.1118.8142.8935.1719.3418.3711.50
Cash & Equivalents12767.1932.4254.4982.2212610562.31200184
Total Debt101135210254------
Net Cash / Debt26.54-68.23-178-20082.2212610562.31200184
Assets1,2411,0811,016935579560493442364343
Liabilities39640246250317617014413480.9478.01
Book Value845680554432402390349308283265
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Omnicell, Inc.
Country United States
Employees 2,780
CEO Randall A. Lipps

Stock Information

Ticker Symbol OMCL
Stock Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Unique Identifier NASDAQ: OMCL
IPO Date August 7, 2001

Description

Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies worldwide. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems used in hospitals and retail pharmacies for handling the stocking and retrieval of boxed medications. In addition, the company provides single dose automation solutions to fill and label for incoming prescriptions; medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings; automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; and semi-automated filling equipment for the long-term care institutional pharmacy. Further, it offers Omnicell Patient Engagement, a web-based nexus of solutions; and patient communication tools, such as interactive voice response, outbound communications, and mobile app. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was founded in 1992 and is headquartered in Mountain View, California.